Skip to main content
Alphatec Holdings, Inc. logo

Alphatec Holdings, Inc. — Investor Relations & Filings

Ticker · ATEC ISIN · US02081G2012 LEI · 549300EZE8CQ8K65FS24 US Manufacturing
Open in API
Filings indexed 1,276 across all filing types
Latest filing 2020-10-13 Regulatory Filings
Country US United States of America
Listing US ATEC

About Alphatec Holdings, Inc.

https://atecspine.com/

Alphatec Holdings, Inc. is a medical technology company that designs, develops, and markets technologies for the surgical treatment of spinal disorders. The company is focused on providing comprehensive procedural solutions that aim to revolutionize the approach to spine surgery. Its portfolio includes spinal fusion technology and other innovative systems designed to improve surgical predictability and patient outcomes. ATEC emphasizes an approach it calls the 'Organic Innovation Machine' to create integrated solutions for surgeons and the broader spine community.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes announcements of preliminary unaudited financial results for the third quarter ended September 30, 2020, and a public offering of common stock. It references press releases attached as exhibits but does not contain full financial statements or detailed financial analysis itself. The document is primarily an announcement of events and updates rather than a full financial report or earnings release. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories.
2020-10-13 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(5) related to a public offering of common stock by Alphatec Holdings, Inc. It includes detailed information about the offering, underwriting, risk factors, use of proceeds, and other related disclosures typical of a prospectus supplement. The document is not a financial report, earnings release, or management discussion but rather a capital raising document describing the terms and conditions of a securities offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed offering information, confirming it is not merely an announcement or a brief notice.
2020-10-13 English
FORM 4 -
Director's Dealing
2020-10-10 English
FORM 3/A -
Director's Dealing
2020-10-07 English
Regulatory Filings 2020
Regulatory Filings
2020-08-19 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. It is a correspondence related to a securities filing process, specifically about the timing of a registration statement becoming effective. The document is short (1465 characters) and does not contain financial data, report content, or detailed disclosures. It is not a report itself but an administrative request related to a capital markets filing. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and correspondence that do not fit other categories.
2020-08-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.